Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Tesamorelin

Egrifta, TH9507

Quick Stats
Studies 64
Trials 24
Score 4
2013 pubmed 105 citations

Growth hormone in the aging male.

Sattler. Fred R FR

Key Findings

  • GH supplementation in older men adds ~2 kg lean mass and reduces fat mass.
  • GH does not consistently improve muscle strength, walking speed, or quality of life.
  • Tesamorelin restores natural GH pulses, selectively cuts visceral fat, reduces intima‑media thickness and triglycerides, and improves cognitive function.

Practical Outcomes

  • For biohackers seeking anti‑aging benefits, tesamorelin may be a more targeted option than raw GH, especially for reducing belly fat and supporting brain health. Expect modest muscle gains, but don’t count on major strength or performance boosts. Start with low‑dose protocols under medical supervision and monitor metabolic markers.

Summary

In older men, growth hormone levels drop, leading to loss of muscle, more belly fat, and slower thinking. Giving growth hormone can add about 2 kg of lean muscle and cut fat, but it doesn’t clearly make you stronger or feel better. A drug called tesamorelin, which tricks the body into releasing its own growth hormone, can lower belly fat, improve blood vessel health, lower triglycerides, and boost cognition in seniors.

Abstract

Secretion of growth hormone (GH) and IGF-1 levels decline during advancing years-of-life. These changes (somatopause) are associated with loss of vitality, muscle mass, physical function, together with the occurrence of frailty, central adiposity, cardiovascular complications, and deterioration of mental function. For GH treatment to be considered for anti-aging, improved longevity, organ-specific function, or quality of life should be demonstrable. A limited number of controlled studies suggest that GH supplementation in older men increases lean mass by ∼2 kg with similar reductions in fat mass. There is little evidence that GH treatment improves muscle strength and performance (e.g. walking speed or ability to climb stairs) or quality of life. The GHRH agonist (tesamorelin) restores normal GH pulsatility and amplitude, selectively reduces visceral fat, intima media thickness and triglycerides, and improves cognitive function in older persons. This report critically reviews the potential for GH augmentation during aging with emphasis on men since women appear more resistant to treatment.

Study Information

Provider

pubmed

Year

2013

Date

2013-06-18T00:00:00.000Z

DOI

10.1016/j.beem.2013.05.003

Citations

105

References

50